Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New report of two Nemoleontinae species from the Korean Peninsula (Neuroptera, Myrmeleontiformia, Myrmeleontidae).

Biodiversity data journal·2026
Same author

<b>A new species of <i>Dudusa</i> (Lepidoptera: Notodontidae) from the Oriental Region with an annotated checklist of the genus</b>.

Zootaxa·2026
Same author

<b>Two new species of <i>Parobisium</i> (Pseudoscorpiones: Neobisiidae) Chamberlin, 1930 from South Korea, with a preliminary phylogeny of the genus</b>.

Zootaxa·2026
Same author

A new record of the southern erebid moth species, <i>Hypena nakajimai</i> Kishida, 2010 (Lepidoptera, Erebidae), from Korea with molecular analyses.

Biodiversity data journal·2026
Same author

Korean dragon pseudoscorpions revisited: a taxonomic review of Allochthonius (Pseudoscorpiones: Pseudotyrannochthoniidae) Chamberlin, 1929 with three new species.

PeerJ·2026
Same author

Predictors of Massive Transfusion in Adult Blunt Trauma Patients: Analysis of a Nationwide Trauma Registry in Korea.

Journal of Korean medical science·2026

Related Experiment Video

Updated: Jul 18, 2026

Multi-Modal Home Sleep Monitoring in Older Adults
07:40

Multi-Modal Home Sleep Monitoring in Older Adults

Published on: January 26, 2019

7.7K

A multimodal screening system for elderly neurological diseases based on deep learning.

Sangyoung Park1, Changho No1, Sora Kim1

  • 1Department of Electrical and Electronic Engineering, Hanyang University ERICA, Ansan, 15588, South Korea.

Scientific Reports
|November 29, 2023
PubMed
Summary

This study introduces a deep learning algorithm for neurological disease screening, using human landmarks and voice data. The system effectively screens for stroke and Parkinson's disease.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Related Experiment Videos

Last Updated: Jul 18, 2026

Multi-Modal Home Sleep Monitoring in Older Adults
07:40

Multi-Modal Home Sleep Monitoring in Older Adults

Published on: January 26, 2019

7.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Area of Science:

  • Artificial Intelligence
  • Neurology
  • Medical Diagnostics

Background:

  • Neurological diseases require early screening for effective management.
  • Current screening methods can be invasive or require specialized equipment.
  • There is a need for accessible and accurate screening tools for neurological disorders.

Purpose of the Study:

  • To develop and validate a deep learning algorithm for screening neurological diseases.
  • To integrate multi-modal data, including human landmarks and voice, for improved diagnostic accuracy.
  • To assess the effectiveness of various examination protocols and data modalities.

Main Methods:

  • A deep learning algorithm was designed using subnetworks for specific protocols and a feature aggregator.
  • Video data was converted into human landmarks, and voice data was collected.
  • Pre-trained models, including graph neural networks and time-delay neural networks, were used for feature extraction.
  • Multitask learning and data augmentation techniques were employed to enhance model performance.
  • A frame-length staticizer was utilized to capture subtle movements like tremors.

Main Results:

  • The algorithm achieved an Area Under the Curve (AUC) of 0.802 for stroke screening.
  • The system demonstrated an AUC of 0.780 for Parkinson's disease screening.
  • Experiments confirmed the effectiveness of different protocols and data modalities (body parts, voice).

Conclusions:

  • The proposed deep learning approach offers an effective method for screening neurological diseases.
  • Integrating human landmark and voice data enhances screening capabilities.
  • The system shows promise as an accessible and accurate tool for early detection of neurological conditions.